857
Views
8
CrossRef citations to date
0
Altmetric
Food & Nutrition Science (Note)

Sulforaphene attenuates multinucleation of pre-osteoclasts by suppressing expression of cell–cell fusion-associated genes DC-STAMP, OC-STAMP, and Atp6v0d2

, , , &
Pages 1220-1223 | Received 15 Dec 2016, Accepted 04 Jan 2017, Published online: 30 Jan 2017

References

  • Hadjidakis DJ, Androulakis II. Bone remodeling. Ann N Y Acad Sci. 2006;1092:385–396.10.1196/annals.1365.035
  • Lee ZH, Kim HH. Signal transduction by receptor activator of nuclear factor kappa B in osteoclasts. Biochem Biophys Res Commun. 2003;305:211–214.10.1016/S0006-291X(03)00695-8
  • Boyle WJ, Simonet WS, Lacey DL. Osteoclast differentiation and activation. Nature. 2003;423:337–342.10.1038/nature01658
  • Zhang C, Dou CE, Xu J, et al. DC-STAMP, the Key fusion-mediating molecule in osteoclastogenesis. J Cell Physiol. 2014;229:1330–1335.10.1002/jcp.v229.10
  • Khan UA, Hashimi SM, Bakr MM, et al. Foreign body giant cells and osteoclasts are TRAP positive, have podosome-belts and both require OC-STAMP for cell fusion. J Cell Biochem. 2013;114:1772–1778.10.1002/jcb.v114.8
  • Lee SH, Rho J, Jeong D, et al. v-ATPase V0 subunit d2-deficient mice exhibit impaired osteoclast fusion and increased bone formation. Nat Med. 2006;12:1403–1409.
  • Byun S, Shin SH, Park J, et al. Sulforaphene suppresses growth of colon cancer-derived tumors via induction of glutathione depletion and microtubule depolymerization. Mol Nutr Food Res. 2016;60:1068–1078.10.1002/mnfr.v60.5
  • Yang M, Teng W, Qu Y, et al. Sulforaphene inhibits triple negative breast cancer through activating tumor suppressor Egr1. Breast Cancer Res Treat. 2016;158:277–286.10.1007/s10549-016-3888-7
  • Takagi T, Inoue H, Takahashi N, et al. Sulforaphane inhibits osteoclast differentiation by suppressing the cell–cell fusion molecules DC-STAMP and OC-STAMP. Biochem Biophys Res Commun. 2017;483:718–724.
  • Yagi M, Miyamoto T, Sawatani Y, et al. DC-STAMP is essential for cell-cell fusion in osteoclasts and foreign body giant cells. J Exp Med. 2005;202:345–351.10.1084/jem.20050645
  • Miyamoto H, Suzuki T, Miyauchi Y, et al. Osteoclast stimulatory transmembrane protein and dendritic cell–specific transmembrane protein cooperatively modulate cell–cell fusion to form osteoclasts and foreign body giant cells. J Bone Miner Res. 2012;27:1289–1297.10.1002/jbmr.1575
  • Kim K, Lee SH, Ha Kim J, et al. NFATc1 induces osteoclast fusion via up-regulation of Atp6v0d2 and the dendritic cell-specific transmembrane protein (DC-STAMP). Mol Endocrinol. 2008;22:176–185.10.1210/me.2007-0237
  • Yang M, Birnbaum MJ, MacKay CA, et al. Osteoclast stimulatory transmembrane protein (OC-STAMP), a novel protein induced by RANKL that promotes osteoclast differentiation. J Cell Physiol. 2008;215:497–505.10.1002/(ISSN)1097-4652

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.